IRON
Disc Medicine, Inc.Company with tickers: IRON
CIK
1816736
CUSIP
254604101
Shares Outstanding
38,199,089
Website
https://www.discmedicine.com
Investor Relations
https://ir.discmedicine.com/
13F Activity (30d)
6 filings
2 filers
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding IRON
164 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Strategic Advisers Fidelity U.S. Total Stock Fund | — | 1,656,623 | $110,364,224 | 0.05% | Long | 2026-02-28 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | — | 1,012,048 | $64,710,349 | 0.87% | Long | 2026-03-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 988,969 | $63,234,678 | 0.00% | Long | 2026-03-31 | |
| Select Health Care Portfolio | — | 650,000 | $43,303,000 | 0.70% | Long | 2026-02-28 | |
| iShares Russell 2000 ETF | — | 669,388 | $42,800,669 | 0.06% | Long | 2026-03-31 | |
| Select Biotechnology Portfolio | — | 532,174 | $35,453,432 | 0.66% | Long | 2026-02-28 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 504,986 | $32,288,805 | 0.25% | Long | 2026-03-31 | |
| Eventide Healthcare & Life Sciences Fund | — | 395,235 | $25,271,326 | 1.59% | Long | 2026-03-31 | |
| JPMorgan Mid Cap Growth Fund | — | 385,709 | $24,662,233 | 0.22% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 354,366 | $22,658,162 | 0.03% | Long | 2026-03-31 | |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund | — | 317,503 | $20,301,142 | 0.25% | Long | 2026-03-31 | |
| JPMorgan Small Cap Growth Fund | — | 288,645 | $18,455,961 | 0.85% | Long | 2026-03-31 | |
| iShares Russell 2000 Growth ETF | — | 224,443 | $14,350,885 | 0.12% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 214,889 | $13,740,003 | 0.17% | Long | 2026-03-31 | |
| VIP Mid Cap Portfolio | — | 208,900 | $13,357,066 | 0.17% | Long | 2026-03-31 | |
| PGIM Jennison Health Sciences Fund | — | 198,021 | $13,192,159 | 0.90% | Long | 2026-02-27 | |
| Fidelity U.S. Equity Central Fund | — | 190,000 | $12,148,600 | 0.06% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 186,605 | $11,931,524 | 0.11% | Long | 2026-03-31 | |
| Loomis Sayles Small Cap Growth Fund | — | 177,485 | $11,348,391 | 0.59% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 166,425 | $11,087,234 | 0.03% | Long | 2026-02-28 | |
| Schwab U.S. Small-Cap ETF | — | 154,846 | $10,315,841 | 0.05% | Long | 2026-02-28 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 123,594 | $8,233,832 | 0.05% | Long | 2026-02-28 | |
| abrdn Healthcare Investors | HQH | 127,312 | $8,140,329 | 0.72% | Long | 2026-03-31 | |
| VIP Health Care Portfolio | — | 114,000 | $7,289,160 | 0.73% | Long | 2026-03-31 | |
| JNL/JPMorgan MidCap Growth Fund | — | 106,080 | $6,782,755 | 0.22% | Long | 2026-03-31 | |
| abrdn Life Sciences Investors | HQL | 99,339 | $6,351,736 | 1.13% | Long | 2026-03-31 | |
| JPMorgan Small Cap Blend Fund | — | 93,185 | $5,958,249 | 0.42% | Long | 2026-03-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 86,558 | $5,766,494 | 0.09% | Long | 2026-02-27 | |
| abrdn Healthcare Opportunities Fund | THQ | 86,107 | $5,505,682 | 0.76% | Long | 2026-03-31 | |
| Fidelity Advisor Small Cap Fund | — | 77,000 | $5,129,740 | 0.23% | Long | 2026-02-28 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 73,237 | $4,879,049 | 0.02% | Long | 2026-02-28 | |
| U.S. MICRO CAP PORTFOLIO | — | 54,689 | $4,228,553 | 0.06% | Long | 2026-01-31 | |
| BNY Mellon Small/Mid Cap Growth Fund | — | 65,330 | $4,177,200 | 0.55% | Long | 2026-03-31 | |
| abrdn World Healthcare Fund | THW | 62,856 | $4,019,013 | 0.84% | Long | 2026-03-31 | |
| Fidelity Total Market Index Fund | — | 59,678 | $3,975,748 | 0.00% | Long | 2026-02-28 | |
| Fidelity Growth Company Fund | — | 54,692 | $3,643,581 | 0.00% | Long | 2026-02-28 | |
| Small Cap Growth Stock Portfolio | — | 56,227 | $3,595,154 | 0.49% | Long | 2026-03-31 | |
| Select Pharmaceuticals Portfolio | — | 53,800 | $3,584,156 | 0.24% | Long | 2026-02-28 | |
| JPMorgan Mid Cap Equity Fund | — | 53,479 | $3,419,447 | 0.06% | Long | 2026-03-31 | |
| Fidelity Series Total Market Index Fund | — | 46,971 | $3,129,208 | 0.00% | Long | 2026-02-28 | |
| Multi-Manager Small Cap Equity Strategies Fund | — | 42,865 | $2,855,666 | 0.23% | Long | 2026-02-28 | |
| Master Small Cap Index Series | — | 44,647 | $2,854,729 | 0.06% | Long | 2026-03-31 | |
| Fidelity Advisor Mid Cap II Fund | — | 43,500 | $2,781,390 | 0.17% | Long | 2026-03-31 | |
| HARTFORD SMALL CAP GROWTH HLS FUND | — | 41,208 | $2,634,840 | 0.50% | Long | 2026-03-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | — | 40,127 | $2,565,720 | 0.00% | Long | 2026-03-31 | |
| T.Rowe Price Small Cap Growth Portfolio | — | 40,097 | $2,563,802 | 0.24% | Long | 2026-03-31 | |
| VIP Stock Selector Portfolio | — | 40,000 | $2,557,600 | 0.06% | Long | 2026-03-31 | |
| U.S. SMALL CAP PORTFOLIO | — | 31,496 | $2,435,271 | 0.01% | Long | 2026-01-31 | |
| T. Rowe Price Small-Mid Cap ETF | — | 37,176 | $2,377,033 | 0.15% | Long | 2026-03-31 | |
| Strategic Advisers U.S. Total Stock Fund | — | 34,708 | $2,312,247 | 0.00% | Long | 2026-02-28 |
Showing 1–50 of 164 positions